Hydroxyzine HCl Oral Solution
- Manufacturer
- TriRx Hunsville Pharmaceutical Services
- Effective date
- 2024-12-09
- Label type
- HUMAN PRESCRIPTION DRUG LABEL
- Version
- 1
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 20:47:10
Label at a glance#
ProductHydroxyzine HCl Oral Solution
Active ingredientHYDROXYZINE DIHYDROCHLORIDE
Label structure14 sections
Label contents#
Full prescribing information#
Clinical Pharmacology
Indications and Usage
Contraindications
Warnings
Precautions
Geriatric Use
Adverse Reactions I
Adverse Reactions II
Adverse Reactions III
Overdosage
Dosage and Administration
How Supplied
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Products#
Every source-derived product name is available through these pages.
- Hydroxyzine HCl Oral Solution
- WATER
- HYDROXYZINE DIHYDROCHLORIDE
- HYDROXYZINE
- ANHYDROUS CITRIC ACID
- SODIUM BENZOATE
- SUCROSE
- ALCOHOL
- SODIUM HYDROXIDE
- SODIUM CITRATE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 80432-059 | 80432-059-33 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| WATER | 059QF0KO0R | IACT |
| HYDROXYZINE DIHYDROCHLORIDE | 76755771U3 | ACTIB |
| ANHYDROUS CITRIC ACID | XF417D3PSL | IACT |
| SODIUM BENZOATE | OJ245FE5EU | IACT |
| SUCROSE | C151H8M554 | IACT |
| ALCOHOL | 3K9958V90M | IACT |
| SODIUM HYDROXIDE | 55X04QC32I | IACT |
| SODIUM CITRATE | 1Q73Q2JULR | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 28d8eb85-0847-a56b-e063-6294a90acec8 | 28d8eb85-0846-a56b-e063-6294a90acec8 | 2024-12-09 | Warnings, Adverse reactions | 28d8eb85-0847-a56b-e063-6294a90acec8 28d8eb85-0846-a56b-e063-6294a90acec8 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.













